92188-49-3

Usage

Uses

Used in Pharmaceutical Industry:
1-(3-METHOXY-PHENYL)-2-METHYLAMINO-ETHANOL is used as a potential drug candidate for the development of medications targeting various medical conditions. Its unique chemical structure and properties make it a subject of interest for research and development in the pharmaceutical field.
The specific applications and reasons for using 1-(3-METHOXY-PHENYL)-2-METHYLAMINO-ETHANOL in the pharmaceutical industry are not explicitly mentioned in the provided materials. However, its potential pharmacological properties and structural features suggest that it may be explored for the development of treatments for a range of medical conditions. Further research and development are required to fully understand its therapeutic potential and optimize its use in the pharmaceutical industry.

InChI:InChI=1/C10H15NO2/c1-11-7-10(12)8-4-3-5-9(6-8)13-2/h3-6,10-12H,7H2,1-2H3

Upstream product

• 1477-63-0 Phenylephrine 
• 32017-77-9 2-(m-methoxyphenyl)oxirane 
• 74-89-5 methylamine 
• 69728-91-2 N-acetyl-1-(3-hydroxyphenyl)-2-methylaminoethanol 
• 74-88-4 methyl iodide 

Downstream Products

• 672326-38-4 C₂₇H₂₈N₃SO₄Cl 
• 387356-02-7 2-methylamino-N-nitroso-1-(m-methoxyphenyl)-1-ethanol 
• 556025-25-3 rac N-(4-chlorobenzyl)-9-{[[2-hydroxy-2-(3-methoxyphenyl)ethyl](methyl)amino]methyl}-1-methyl-2,7-dioxo-2,3-dihydro-1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamide 

Relevant academic research and scientific papers

2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases

A novel series of 2-aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides have been identified as potent antivirals against human herpesviruses. These compounds demonstrate broad-spectrum inhibition of the herpesvirus polymerases HCMV, HSV-1, EBV, and VZV with high specificity compared to human DNA polymerases.

ARYL-ETHANOLAMINE DERIVATIVES AS ANTIVIRAL AGENTS

The present invention provides a compound of formula as describedherein, which are useful as antiviral agents, in particular, as agents against viruses of the herpes family.

Pyridoquinoxaline antivirals

The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof wherein R1, R2 and R3 are as defined in the specification. The compounds are useful for the treatment of viral infections.